| Q-o-Q | REVENUES | OPERATING PROFIT | PROFIT AFTER TAX | EPS | Updated : 20-Sep-21 | Details👇 |
| Consolidated | Jun2021 UnAudited |
Mar2021 UnAudited |
Dec2020 UnAudited |
Sep2020 UnAudited |
Jun2020 UnAudited |
Mar2020 UnAudited |
Dec2019 UnAudited |
Sep2019 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹1,761 Cr | ₹1,839 Cr | ₹1,851 Cr | ₹1,745 Cr | ₹1,694 Cr | ₹1,558 Cr | ₹1,717 Cr | ₹1,567 Cr |
| Expenses | ₹1,371 Cr | ₹1,403 Cr | ₹1,452 Cr | ₹1,353 Cr | ₹1,281 Cr | ₹1,239 Cr | ₹1,273 Cr | ₹1,165 Cr |
| Operating Income | ₹389 Cr | ₹436 Cr | ₹400 Cr | ₹391 Cr | ₹413 Cr | ₹319 Cr | ₹444 Cr | ₹403 Cr |
| Other Income | ₹47 Cr | ₹205 Cr | ₹28 Cr | ₹16 Cr | ₹18 Cr | ₹63 Cr | ₹36 Cr | ₹38 Cr |
| Interest | ₹20 Cr | ₹34 Cr | ₹5 Cr | ₹7 Cr | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹14 Cr |
| Depreciation | ₹195 Cr | ₹184 Cr | ₹186 Cr | ₹178 Cr | ₹167 Cr | ₹152 Cr | ₹144 Cr | ₹132 Cr |
| Profit Before Tax | ₹222 Cr | ₹436 Cr | ₹236 Cr | ₹223 Cr | ₹252 Cr | ₹213 Cr | ₹318 Cr | ₹363 Cr |
| Profit After Tax | ₹165 Cr | ₹366 Cr | ₹187 Cr | ₹200 Cr | ₹171 Cr | ₹168 Cr | ₹234 Cr | ₹263 Cr |
| EPS | ₹0.70 | ₹2.11 | ₹1.41 | ₹1.41 | ₹1.25 | ₹1.03 | ₹1.69 | ₹1.80 |
| Peers & Returns | 1W | 1M | 1Y |
| BIOCON | -2.6% | 5.2% | -19% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -0.3% | 47.1% |
| DIVIS LABORATORIES | 1.7% | 7.3% | 53.8% |
| DR REDDYS LABORATORIES | -1.9% | 4.5% | -9% |
| CIPLA | 1.5% | 5.5% | 19.6% |
| GLAND PHARMA | -1.6% | 2.6% | NA |
| PIRAMAL ENTERPRISES | 5.6% | 6.6% | 95.6% |
| CADILA HEALTHCARE | 1.6% | 3.3% | 37.2% |
| TORRENT PHARMACEUTICALS | 0.2% | 1.5% | 7.4% |
| Revenues | |
|---|---|
| Q-o-Q | -4.25 % |
| Y-o-Y | 3.94 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2021 | ₹1,761 Cr | -4.25 | |
| Mar2021 | ₹1,839 Cr | -0.66 | |
| Dec2020 | ₹1,851 Cr | 6.09 | |
| Sep2020 | ₹1,745 Cr | 3.01 | |
| Jun2020 | ₹1,694 Cr | 8.75 | |
| Mar2020 | ₹1,558 Cr | -9.28 | |
| Dec2019 | ₹1,717 Cr | 9.54 | |
| Sep2019 | ₹1,567 Cr | - | |
| Operating Profit | |
|---|---|
| Q-o-Q | -10.67 % |
| Y-o-Y | -5.81 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2021 | ₹389 Cr | -10.67 | |
| Mar2021 | ₹436 Cr | 9.09 | |
| Dec2020 | ₹400 Cr | 2.07 | |
| Sep2020 | ₹391 Cr | -5.30 | |
| Jun2020 | ₹413 Cr | 29.72 | |
| Mar2020 | ₹319 Cr | -28.28 | |
| Dec2019 | ₹444 Cr | 10.28 | |
| Sep2019 | ₹403 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -6.71 % |
| Y-o-Y | -9.39 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2021 | 22.11% | -6.71 | |
| Mar2021 | 23.7% | 9.82 | |
| Dec2020 | 21.58% | -3.79 | |
| Sep2020 | 22.43% | -8.07 | |
| Jun2020 | 24.4% | 19.26 | |
| Mar2020 | 20.46% | -20.91 | |
| Dec2019 | 25.87% | 0.66 | |
| Sep2019 | 25.7% | - | |
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -55.08 % |
| Y-o-Y | -4.03 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2021 | ₹165 Cr | -55.08 | |
| Mar2021 | ₹366 Cr | 95.41 | |
| Dec2020 | ₹187 Cr | -6.49 | |
| Sep2020 | ₹200 Cr | 16.92 | |
| Jun2020 | ₹171 Cr | 2.33 | |
| Mar2020 | ₹168 Cr | -28.27 | |
| Dec2019 | ₹234 Cr | -11.28 | |
| Sep2019 | ₹263 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -53.11 % |
| Y-o-Y | -7.71 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2021 | 9.34 % | -53.11 | |
| Mar2021 | 19.92 % | 96.84 | |
| Dec2020 | 10.12 % | -11.92 | |
| Sep2020 | 11.49 % | 13.54 | |
| Jun2020 | 10.12 % | -5.86 | |
| Mar2020 | 10.75 % | -20.96 | |
| Dec2019 | 13.6 % | -19.00 | |
| Sep2019 | 16.79 % | - | |
| EPS | |
|---|---|
| Q-o-Q | -66.82 % |
| Y-o-Y | -44.00 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2021 | ₹0.7 | -66.82 | |
| Mar2021 | ₹2.11 | 49.65 | |
| Dec2020 | ₹1.41 | 0.00 | |
| Sep2020 | ₹1.41 | 12.80 | |
| Jun2020 | ₹1.25 | 21.36 | |
| Mar2020 | ₹1.03 | -39.05 | |
| Dec2019 | ₹1.69 | -6.11 | |
| Sep2019 | ₹1.8 | - | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE LARGE MIDCAP | 2.5% | 7.6% | 56.6% |
| S&P BSE 100 | 2.5% | 7.4% | 55.5% |
| S&P BSE CARBONEX | 2.5% | 7.2% | 54.9% |
| S&P BSE 250 LARGEMIDCAP | 2.5% | 7.6% | 57.8% |
| S&P BSE 200 | 2.5% | 7.6% | 57.5% |
| S&P BSE 100 LARGECAP TMC | 2.5% | 7.4% | 55.3% |
| S&P BSE 500 | 2.5% | 7.7% | 59.1% |
| S&P BSE ALLCAP | 2.4% | 7.7% | 60.1% |
| S&P BSE MID CAP | 2.4% | 9.8% | 69.4% |
| S&P BSE MIDSMALLCAP | 2.2% | 8.8% | 76.8% |
| S&P BSE 100 ESG INDEX | 2.1% | 6.5% | 54.7% |
| S&P BSE SENSEX NEXT 50 | 2.1% | 8.9% | 59.4% |
| S&P BSE MIDCAP SELECT INDEX | 1.2% | 7.7% | 63.3% |
| S&P BSE HEALTHCARE | 0.4% | 1.9% | 30.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 200 | 2.5% | 7.8% | 57.6% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 8.3% | 63.2% |
| NIFTY 100 | 2.5% | 7.5% | 55.4% |
| NIFTY 500 | 2.5% | 7.8% | 59.1% |
| NIFTY500 MULTICAP 50:25:25 | 2.4% | 8.1% | NA |
| NIFTY 100 EQUAL WEIGHT | 2.2% | 7.9% | 63.1% |
| NIFTY NEXT 50 | 1.7% | 8.3% | 57.7% |
| NIFTY PHARMA | 1.4% | 3.3% | 16.7% |
| NIFTY HEALTHCARE | 0.6% | 1.5% | NA |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure